LIMA1 and fatty liver disease: Notably, LIMA1 HKO exhibited systematic amelioration of MASLD‐related phenotypes, as indicated by the changes in hepatic steatosis, inflammatory cell infiltration, and hepatic fibrosis in HFD‐fed and CDAHFD‐fed mice.